HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

E.l.f. Priming Alicia Keys Brand, Fans For Global Launch: ‘The World Is Craving A Brand With Soul’

Executive Summary

Coming off its seventh consecutive quarter of net sales growth, E.l.f. expects big things from Keys Soulcare, its third and loftiest brand that is building an online community ahead of initial product launches and a global debut planned for the new year.

You may also be interested in...



E.l.f. Cosmetics Gets Serious About Skin Care With New Product Launches, Awareness Campaign

E.l.f. Skin, now the fourth brand in the firm’s portfolio alongside e.l.f. Beauty, W3ll People, and Keys Soulcare, includes new Blemish Breakthrough and Pure Skin lines of clean, kind products priced at $14 or less.

E.l.f. Cosmetics Will Be Selectively Less Affordable Come March

E.l.f. will raise prices by $1 across SKUs where it has the most pricing power, while maintaining its lowest-priced items where they are now, CEO Tarang Amin said during the firm’s fiscal 2022 third-quarter earnings call. The company raised guidance for the full year, now targeting net sales up to $379m.

E.l.f. Beauty Sales Jump 50% With Makeup Rebound, Online Gaming Push

Gen Z-focused E.l.f. Beauty Inc. booked 50% net sales growth in its fiscal 2022 first quarter with continued improvisation across social media platforms where mainstream players still hesitate to venture.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150686

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel